MP George Freeman says the failed Pfizer bid for Astrazeneca is not a lost opportunity . The pharma sector is radically changing , from being all about the discovery of old style drugs through biological research , to the design of personalized and genetically profiled drugs through research based more in hospitals than pharma factories . Instead , it ensures a focus on the crusade to make the UK a hub for medicine design . Freeman says the UK must look to its public health service to boost research . The government has been criticised by some in Britain and abroad over plans to cut £1billion from spending on drugs development.
MP George Freeman says the failed Pfizer bid for Astrazeneca is not a lost opportunity . Instead , it ensures a focus on the crusade to make the UK a hub for medicine design . Freeman says the UK must look to its public health service to boost research . The government has been criticised by some in Britain and abroad over plans to cut £1billion from spending on drugs development.